1. Home
  2. LCNB vs CCCC Comparison

LCNB vs CCCC Comparison

Compare LCNB & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

HOLD

Current Price

$17.49

Market Cap

205.5M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
CCCC
Founded
1877
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5M
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LCNB
CCCC
Price
$17.49
$2.03
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
29.2K
2.0M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
5.23%
N/A
EPS Growth
220.73
N/A
EPS
1.67
N/A
Revenue
$89,312,000.00
$30,108,000.00
Revenue This Year
$18.04
N/A
Revenue Next Year
$4.36
N/A
P/E Ratio
$10.09
N/A
Revenue Growth
19.58
N/A
52 Week Low
$13.34
$1.09
52 Week High
$17.84
$4.26

Technical Indicators

Market Signals
Indicator
LCNB
CCCC
Relative Strength Index (RSI) 57.17 34.04
Support Level $17.07 $2.00
Resistance Level $17.59 $2.69
Average True Range (ATR) 0.42 0.18
MACD 0.06 -0.07
Stochastic Oscillator 57.64 3.55

Price Performance

Historical Comparison
LCNB
CCCC

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: